These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20438537

  • 1. Plasma exchange in elderly patients.
    Basic-Jukic N, Brunetta B, Kes P.
    Ther Apher Dial; 2010 Apr; 14(2):161-5. PubMed ID: 20438537
    [Abstract] [Full Text] [Related]

  • 2. Complications of therapeutic plasma exchange: experience with 4857 treatments.
    Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z.
    Ther Apher Dial; 2005 Oct; 9(5):391-5. PubMed ID: 16202013
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic plasma exchange in Casablanca.
    Tazi I, Merimi F, Majd A, Benchemsi N.
    Transfus Apher Sci; 2008 Aug; 39(1):45-8. PubMed ID: 18583191
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, Erkurt MA, Sivgin S, Korkmaz S, Okan V, Doğu MH, Unal A, Cetin M, Altuntaş F, Ilhan O.
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK, Ismailogullari S, Turgut N, Erkurt MA, Sari I, Oztekin M, Solmaz M, Eser B, Ersoy AO, Unal A, Cetin M.
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
    Alshekhlee A, Hussain Z, Sultan B, Katirji B.
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
    [Abstract] [Full Text] [Related]

  • 7. Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange.
    Kankirawatana S, Huang ST, Marques MB.
    J Clin Apher; 2007 Sep; 22(5):265-9. PubMed ID: 17722047
    [Abstract] [Full Text] [Related]

  • 8. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A, Buturović-Ponikvar J, Svigelj V, Ponikvar R.
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [Abstract] [Full Text] [Related]

  • 9. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
    Sanjay R, Flanagan J, Sodano D, Gorson KC, Ropper AH, Weinstein R.
    J Clin Apher; 2006 Jul; 21(2):105-10. PubMed ID: 16342192
    [Abstract] [Full Text] [Related]

  • 10. Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective.
    Agreda-Vásquez GP, Espinosa-Poblano I, Sánchez-Guerrero SA, Crespo-Solís E, Cabrera-Vásquez S, López-Salmorán J, Barajas J, Peñaloza-Ramírez P, Tirado-Cárdenas N, Velázquez A.
    J Clin Apher; 2008 Jul; 23(5):163-7. PubMed ID: 18819155
    [Abstract] [Full Text] [Related]

  • 11. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
    Antonic M, Gubensek J, Buturović-Ponikvar J, Ponikvar R.
    Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O, Arat M, Tek I, Ayyildiz E, Ilhan O.
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [Abstract] [Full Text] [Related]

  • 13. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [Abstract] [Full Text] [Related]

  • 14. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
    Shemin D, Briggs D, Greenan M.
    J Clin Apher; 2007 Jun; 22(5):270-6. PubMed ID: 17722046
    [Abstract] [Full Text] [Related]

  • 15. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
    Köhler W, Bucka C, Klingel R.
    J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
    [Abstract] [Full Text] [Related]

  • 16. Physiological changes during and outcome following 'filtration' based continuous plasma exchange in Guillain Barre Syndrome.
    Jayasena YA, Mudalige SP, Manchanayake GS, Dharmapala HL, Kumarasiri RP, Weerasinghe VS, Goonasekera CD.
    Transfus Apher Sci; 2010 Apr; 42(2):109-13. PubMed ID: 20122871
    [Abstract] [Full Text] [Related]

  • 17. [Guillain-Barré syndrome].
    Raphaël JC.
    Rev Prat; 2005 Apr 30; 55(8):823-7. PubMed ID: 15999835
    [Abstract] [Full Text] [Related]

  • 18. Changes in indications for therapeutic plasma exchange over the last 27 years in Croatia.
    Brunetta Gavranić B, Bašić-Jukić N, Kes P.
    Ther Apher Dial; 2011 Dec 30; 15(6):587-92. PubMed ID: 22107696
    [Abstract] [Full Text] [Related]

  • 19. Trend of indications for therapeutic plasma exchange at an Iranian university hospital.
    Shahidi S, Memarzadeh M, Kamali M, Naini AE.
    Transfus Apher Sci; 2011 Apr 30; 44(2):119-22. PubMed ID: 21334978
    [Abstract] [Full Text] [Related]

  • 20. [Present treatment of Guillain-Barre syndrome].
    Raphaël JC.
    Bull Acad Natl Med; 2004 Apr 30; 188(1):87-94; discussion 94-5. PubMed ID: 15368928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.